139 related articles for article (PubMed ID: 24959399)
1. Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms.
Peraman R; Lalitha KV; Raja NM; Routhu HB
Sci Pharm; 2014; 82(2):281-93. PubMed ID: 24959399
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Stability-Indicating Assay of Etofenamate by RP-HPLC and Characterization of Degradation Products.
Peraman R; Nayakanti D; Dugga HH; Kodikonda S
Sci Pharm; 2013; 81(4):1017-28. PubMed ID: 24482770
[TBL] [Abstract][Full Text] [Related]
3. Selective separation, detection of zotepine and mass spectral characterization of degradants by LC-MS/MS/QTOF.
Talluri MVNK; Kandimalla NR; Bandu R; Chundi D; Marupaka R; Srinivas R
J Pharm Anal; 2014 Apr; 4(2):107-116. PubMed ID: 29403872
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a stability indicating RP-UPLC method for determination of quetiapine in pharmaceutical dosage form.
Trivedi RK; Patel MC
Sci Pharm; 2011; 79(1):97-111. PubMed ID: 21617775
[TBL] [Abstract][Full Text] [Related]
5. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
6. Development of a Stability-Indicating RP-HPLC Method for the Determination of Rupatadine and its Degradation Products in Solid Oral Dosage Form.
Trivedi HK; Patel MC
Sci Pharm; 2012; 80(4):889-902. PubMed ID: 23264938
[TBL] [Abstract][Full Text] [Related]
7. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
8. Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enrofloxacin and Its Degradation Products in Tablet Dosage Forms.
Chakravarthy VA; Sailaja BB; Kumar AP
J Anal Methods Chem; 2015; 2015():735145. PubMed ID: 25705547
[TBL] [Abstract][Full Text] [Related]
9. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
Sharma N; Rao SS; Reddy AM
J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
[TBL] [Abstract][Full Text] [Related]
10. Validated Stability-Indicating RP-HPLC Method for the Estimation of Degradation Behaviour of Organic Peroxide and Third-Generation Synthetic Retinoids in Topical Pharmaceutical Dosage Formulation.
Roy C; Panigrahi L; Chakrabarty J
Sci Pharm; 2015; 83(2):321-38. PubMed ID: 26839821
[TBL] [Abstract][Full Text] [Related]
11. Development of a Stability-Indicating RP-UPLC Method for Rapid Determination of Metaxalone and its Degradation Products in Solid Oral Dosage Form.
Trivedi RK; Patel MC
Sci Pharm; 2012; 80(2):353-66. PubMed ID: 22896822
[TBL] [Abstract][Full Text] [Related]
12. High-Performance Liquid Chromatography and Liquid Chromatography/Mass Spectrometry Studies on Stress Degradation Behavior of Sulfapyridine and Development of a Validated, Specific, Stability-Indicating HPLC Assay Method.
Kapoor B; Gupta R; Gulati M; Singh SK; Khatik GL; Chawla M; Nagappan KV; Khursheed R; Kumar R
Assay Drug Dev Technol; 2020 Apr; 18(3):119-133. PubMed ID: 32267712
[TBL] [Abstract][Full Text] [Related]
13. A Stability-Indicating HPLC-DAD Method for Determination of Ferulic Acid into Microparticles: Development, Validation, Forced Degradation, and Encapsulation Efficiency.
Nadal JM; Toledo Mda G; Pupo YM; Padilha de Paula J; Farago PV; Zanin SM
J Anal Methods Chem; 2015; 2015():286812. PubMed ID: 26075139
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Process-Related Impurities and Degradation Products of Rabeprazole Sodium in Pharmaceutical Formulation.
Kumar N; Sangeetha D
Sci Pharm; 2013; 81(3):697-711. PubMed ID: 24106668
[TBL] [Abstract][Full Text] [Related]
15. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
[TBL] [Abstract][Full Text] [Related]
16. A novel validated stability indicating high performance liquid chromatographic method for estimation of degradation behavior of ciprofloxacin and tinidazole in solid oral dosage.
Vaghela BK; Rao SS
J Pharm Bioallied Sci; 2013 Oct; 5(4):298-308. PubMed ID: 24302838
[TBL] [Abstract][Full Text] [Related]
17. Stability-indicating HPLC method for the determination of darunavir ethanolate.
Reddy BV; Jyothi G; Reddy BS; Raman NV; Reddy KS; Rambabu C
J Chromatogr Sci; 2013; 51(5):471-6. PubMed ID: 23097581
[TBL] [Abstract][Full Text] [Related]
18. Chromatographic reversed HPLC and TLC-densitometry methods for simultaneous determination of serdexmethylphenidate and dexmethylphenidate in presence of their degradation products-with computational assessment.
Kelani KM; Nassar AMW; Omran GA; Morshedy S; Elsonbaty A; Talaat W
BMC Chem; 2023 Jul; 17(1):76. PubMed ID: 37454105
[TBL] [Abstract][Full Text] [Related]
19. A developed and validated stability-indicating reverse-phase high performance liquid chromatographic method for determination of cefdinir in the presence of its degradation products as per International Conference on Harmonization guidelines.
Hamrapurkar P; Patil P; Phale M; Gandhi M; Pawar S
Pharm Methods; 2011 Jan; 2(1):15-20. PubMed ID: 23781424
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
